We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
92 hedge funds and large institutions have $167M invested in Madrigal Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
124% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 17
12% more funds holding
Funds holding: 82 → 92 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $213M → $167M (-$46.5M)
57% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $2.35M
Holders
92
Holders Change
+10
Holders Change %
+12.2%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
38
Reduced
17
Closed
6
Calls
$1.02M
Puts
$2.35M
Net Calls
-$1.33M
Net Calls Change
+$525K
Top Buyers
| 1 |
JG
Jefferies Group
New York
|
+$3.58M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$1.6M |
| 3 |
Renaissance Technologies
New York
|
+$1.5M |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.28M |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$1.2M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$1.11M |
| 2 |
SG Americas Securities
New York
|
-$1.09M |
| 3 |
NC
NBW Capital
Boston,
Massachusetts
|
-$940K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$338K |
| 5 |
Barclays
London,
United Kingdom
|
-$179K |
